Dr. Herman E. Blomeier, MD

Dr. Blomeier practices at Northshore Immediate Care Center - HOPD in Skokie, Illinois.

Dr. Blomeier's NPI, 1003011800, was assigned on June 20, 2007. Dr. Blomeier graduated from Sidney Kimmel Medical College in 2001. Dr. Blomeier holds Illinois license 36111253.

Dr. Blomeier's primary practice is Northshore Immediate Care Center - HOPD, at 9977 Woods Drive, Skokie, IL 60077.

Dr. Blomeier's primary practice is Northshore Immediate Care Center - HOPD in Skokie, Illinois. Dr. Blomeier is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Blomeier to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Blomeier's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blomeier practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Blomeier's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Blomeier is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Blomeier is licensed in Illinois.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, osteoporosis, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Dr. Blomeier treats.

CMS data shows 1,301 Medicare services from Dr. Blomeier across 7 procedure codes in 2024, for 365 Medicare patients. Medicare paid $80,598 for them.

CMS counts 365 Medicare patients who saw Dr. Blomeier in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blomeier's median patient age at 70, with 57% women.

In 2024, Dr. Blomeier wrote 3,369 Medicare Part D claims for 409 patients. 35% of them were for generic drugs. CMS names the drug for 3,113 of them, across 50 drugs with 11 or more claims each, at $1,427,918 in total drug cost. In 2023, CMS named 3,026 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Blomeier for performance year 2024, reported as part of a group. Dr. Blomeier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blomeier as offering telehealth.

Dmand AI links 3 papers to Dr. Blomeier. The most frequent topics are Mice, Inbred C57BL. Dr. Blomeier's most frequent co-authors are Amy Gross Aronovitz, MD and Alvin C. Powers, MD.

Dmand AI links Dr. Blomeier to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 2 general payments to Dr. Blomeier from 1 drug or device company from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $120.

Dmand AI lists 1 award for Dr. Blomeier, most recently CMS Stage 1 EHR in 2013.

Dr. Blomeier graduated from Sidney Kimmel Medical College in 2001. Dr. Blomeier is a member of ENDO.

Dr. Blomeier is in network with 16 carriers, including Aetna, Cigna and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.